Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.

Somaiah N, Simon NG, Simon GR.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S342-68. doi: 10.1097/JTO.0b013e318271c798. Review. No abstract available.

2.

Molecular targeted agents and biologic therapies for non-small cell lung cancer.

Somaiah N, Simon GR.

J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S434-54. doi: 10.1097/01.JTO.0000391362.10517.1f. No abstract available.

3.

Molecular targeted agents and biologic therapies for lung cancer.

Somaiah N, Simon GR.

J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1758-85. doi: 10.1097/01.JTO.0000407557.30793.a6. No abstract available.

4.

Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer.

Govindan R.

J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S433. doi: 10.1097/JTO.0b013e3181fd6fe1. No abstract available.

5.

A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.

Simon GR, Somaiah N.

Clin Lung Cancer. 2014 Jan;15(1):21-51. doi: 10.1016/j.cllc.2013.11.009. Epub 2013 Nov 21.

PMID:
24377743
6.

Molecularly targeted therapies in locally advanced non-small-cell lung cancer.

Devarakonda S, Morgensztern D, Govindan R.

Clin Lung Cancer. 2013 Sep;14(5):467-72. doi: 10.1016/j.cllc.2013.03.005. Epub 2013 May 14. Review.

PMID:
23684057
7.

Phosphatidylinositol-3-kinase pathway.

Reckamp KL.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S383-4. doi: 10.1097/JTO.0b013e31826df11c. Review. No abstract available.

8.

Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.

Massarelli E, Papadimitrakopoulou VA.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S379-82. doi: 10.1097/JTO.0b013e31826df0f0. Review. No abstract available.

9.

Update on HER1-3 in advanced non-small-cell lung cancer.

Horn L, Lovly C.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S369-71. doi: 10.1097/JTO.0b013e31826defaa. Review. No abstract available.

10.

Targeting MEK for the treatment of non-small-cell lung cancer.

Goldman JW, Garon EB.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S377-8. doi: 10.1097/JTO.0b013e31826df0bc. Review. No abstract available.

11.

Hsp90 inhibitors.

Pillai RN, Ramalingam SS.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S407-8. doi: 10.1097/JTO.0b013e31826df2bb. Review. No abstract available.

12.

Doubling down with inhibitors of Notch and Hedgehog signaling pathways.

Weiss GJ.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S409-10. doi: 10.1097/JTO.0b013e31826df2cd. Review. No abstract available.

13.

Targeted therapy in lung cancer: lessons learned from past experiences.

Subramanian J, Waqar SN, Govindan R.

J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1786-8. doi: 10.1097/01.JTO.0000407558.38416.c5. No abstract available.

14.

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].

Italiano A, Besse B, Planchard D, Soria JC.

Bull Cancer. 2007;94(7 Suppl):F177-88. Review. French.

PMID:
17964994
15.

Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer.

Riess JW, Neal JW.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S385-6. doi: 10.1097/JTO.0b013e31826df166. Review. No abstract available.

16.

Clinical Trials of PD-1 and PD-L1 inhibitors in NSCLC.

[No authors listed]

Clin Adv Hematol Oncol. 2014 Jan;12(1 Suppl 1):14-6. No abstract available.

PMID:
24852398
17.

[Targeted therapies and radiation therapy in non-small cell lung cancer].

Rivera S, Quéro L, Wong Hee Kam S, Maylin C, Deutsch E, Hennequin C.

Cancer Radiother. 2011 Oct;15(6-7):527-35. doi: 10.1016/j.canrad.2011.07.234. Epub 2011 Aug 31. Review. French.

PMID:
21885318
18.

Three cheers for targeted therapy in non-small cell lung cancer... When we hit the target!

Codacci-Pisanelli G, Frati L, Mini E.

J Chemother. 2011 Aug;23(4):245-6. No abstract available.

PMID:
21803707
19.

Targeted lung cancer therapies.

Farmer G.

Nat Rev Drug Discov. 2004 Jul;3(7):547-8. No abstract available.

PMID:
15272497
20.

New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.

Zarogoulidis P, Yarmus L, Zarogoulidis K.

Ther Deliv. 2013 Oct;4(10):1221-3. doi: 10.4155/tde.13.95. No abstract available.

PMID:
24116905

Supplemental Content

Support Center